160 related articles for article (PubMed ID: 17979488)
1. Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.
da Silva GN; Bacchi MM; Rainho CA; de Oliveira DE
Arch Pathol Lab Med; 2007 Nov; 131(11):1691-6. PubMed ID: 17979488
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.
Hohaus S; Giachelia M; Massini G; Vannata B; Criscuolo M; Martini M; D'Alo' F; Voso MT; Larocca LM; Leone G
Leuk Res; 2009 Oct; 33(10):1352-6. PubMed ID: 19201467
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.
Minnicelli C; Barros MH; Klumb CE; Romano SO; Zalcberg IR; Hassan R
PLoS One; 2012; 7(9):e46005. PubMed ID: 23029361
[TBL] [Abstract][Full Text] [Related]
4. Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma.
Cordano P; Lake A; Shield L; Taylor GM; Alexander FE; Taylor PR; White J; Jarrett RF
Br J Haematol; 2005 Feb; 128(4):493-5. PubMed ID: 15686457
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas.
Dhiab MB; Ziadi S; Mestiri S; Gacem RB; Ksiaa F; Trimeche M
Cell Oncol (Dordr); 2015 Dec; 38(6):453-62. PubMed ID: 26350502
[TBL] [Abstract][Full Text] [Related]
6. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
[TBL] [Abstract][Full Text] [Related]
8. Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.
Martin P; Martínez-Velasquez J; Coronado MJ; Krsnik I; Provencio M; Navarro B; Moraru M; Bellas C; Vilches C; Gomez-Lozano N
Leuk Lymphoma; 2017 Feb; 58(2):438-444. PubMed ID: 27267403
[TBL] [Abstract][Full Text] [Related]
9. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
[TBL] [Abstract][Full Text] [Related]
10. A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.
Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadié M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjosé S; Lathrop M; Melbye M; Brennan P; Diepstra A; van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1838-43. PubMed ID: 26404960
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
12. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.
Cunningham LM; Chapman C; Dunstan R; Bell MC; Joske DJ
Leuk Lymphoma; 2003 Feb; 44(2):251-5. PubMed ID: 12688341
[TBL] [Abstract][Full Text] [Related]
14. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.
Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B
Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854
[TBL] [Abstract][Full Text] [Related]
15. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
16. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
17. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
[TBL] [Abstract][Full Text] [Related]
19. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
[TBL] [Abstract][Full Text] [Related]
20. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
Lake A; Shield LA; Cordano P; Chui DT; Osborne J; Crae S; Wilson KS; Tosi S; Knight SJ; Gesk S; Siebert R; Hay RT; Jarrett RF
Int J Cancer; 2009 Sep; 125(6):1334-42. PubMed ID: 19507254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]